Abstract
To screen or not to screen for prostate cancer remains a controversial question. The increasing incidence, for a large part explained by a rising awareness and active search for the disease, and the slightly increasing mortality, presumably real, unquestionably call for intensified efforts to improve the control of prostate cancer. When the patients become symptomatic they are usually out of the reach of radical treatment. Cure of the disease, if cure is possible, can be hoped for only in case the patient is identified in the asymptomatic stage.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
